Advertisement · 728 × 90
#
Hashtag
#ActivistInvestors
Advertisement · 728 × 90
Preview
SEC won’t weigh in on most no-action requests this proxy season, including ESG submissions The change “has the potential to end shareholder proposals as we know them,” a former SEC corporation finance division director told ESG Dive.

Well, this makes total sense in Trump II. Let corporations do anything they please with respect to shareholder actions and hope nobody has the will and resources to file suit. I'm generally no fan of #ActivistInvestors, but their time may be coming...

www.esgdive.com/news/sec-to-...

0 0 0 0
Preview
Activist Investors to Juice Bank M&A: A New Wave of Consolidation? The recent $10.9 billion sale of Comerica to Fifth Third Bancorp has sent shockwaves through the banking industry, with many experts predicting a new wave of consolidation driven by activist investors...

Activist Investors Take Aim at Regional Banks! HoldCo Asset Management is targeting Eastern Bankshares, First Interstate, and Columbia Banking System for potential sales or strategic shifts. What's next? shorturl.at/NRmNx #BankingIndustry #ActivistInvestors

1 0 0 0
Preview
From vultures to defenders, Japan private equity deals head for record year By Anton Bridge and Miho Uranaka TOKYO (Reuters) -Take-private deals in Japan are likely to hit a record high this year, exceeding the $40.3 billion total racked up in 2023, according to private equity funds and advisers, as companies bow to pressure to improve returns for investors. Japanese companies once feared private equity as "hagetaka", or vultures. Now they are increasingly open to buyouts and giving up their once-prized listed status in the face of calls from activist investors and the Tokyo Stock Exchange to overhaul capital management and cross-shareholdings. Private equity players say there is unprecedented interest from their backers in opportunities in Japan, with the spate of deals this year bucking a global slowdown in such activity. In the year to August 20, private equity deals totalled $27.6 billion, almost triple the $9.5 billion over the same period in 2024, Dealogic data shows. Prominent deals announced in the past month include Blackstone’s $3.5 billion offer for engineering staffing firm TechnoPro and EQT’s $2.7 billion bid for elevator-maker Fujitec. "We have an extremely rich pipeline of deals," said Kazuhiro Yamada, managing director at Carlyle Japan. "Of the more than 300 opportunities Carlyle Japan is seeing across its three core sectors, around 30 have a chance of closing in the next 12 to 18 months," Yamada said. The Tokyo Stock Exchange has set out stricter governance criteria, intended to make listed firms more attractive for investment, which is forcing companies to explore options including delisting. 3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads. The bourse’s reform push, a response to Japan’s unusally high number of undervalued stocks, has sparked a slew of share buybacks, asset sales and management buyouts. PRIVATE EQUITY VS ACTIVIST INVESTORS Growing activist activity, which is seen as potentially preceding a go-private deal, is encouraging speculation on the stock price of targeted companies. "Particularly after activists come in, speculators can push the share price up so high that nobody could make an offer," said Akihiko Manaka, co-head of investment banking and head of M&A in Japan at Bank of America. The share price of Fujitec more than doubled in the three years between activist Oasis first targeting the company and EQT’s bid in July. The private equity firm’s offer was a discount to the market price. "By the time a company reaches the point of needing to privatise, it may be already too late to begin considering potential partners," said Kohei Fukushima, a director at EQT who worked on the Fujitec deal. To avoid that situation, companies are increasingly talking to private equity firms before management becomes the target of investors agitating for change, industry players say. "In some sense it has become a natural strategic option," said Eiji Yatagawa, a partner at KKR in Japan. "Some management are taking proactive action and considering privatisation even before activists become shareholders," Yatagawa said. Funds say that now up to around half of their discussions with companies are initiated by the companies themselves. 3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads. Going private provides an opportunity for existing management to undertake restructuring away from the eye of the public market. "At the C-suite level, the general practice among PE funds is to at least give existing management a shot," said Jeremy White, partner and global co-head of M&A at law firm Morrison Foerster in Tokyo. Funds say Japan’s robust capital market supports later relistings and companies pursuing mergers and acquisitions and other funds also offer potential exit opportunities. "There’s a lot of capital to deploy in the industry and as a result, private equity firms’ positioning as potential buyers is strengthening," he said. That's one option, but what if there are better opportunities hiding in plain sight? Investing.com's ProPicks AI has identified growth stocks that often get overlooked by individual investors. Compare your choice against our global range of AI-selected picks - with 3 out of 4 beating their benchmark index year to date and 98% in the green. Get fresh new picks every month, now available at 50% off while our Summer Sale lasts. Hurry, offer ends soon!

Click Subscribe #PrivateEquity #JapanFinance #InvestmentTrends #ActivistInvestors #TakePrivateDeals

0 0 0 0
Preview
Factbox-Healthcare firms see growing activist investor involvement in the past year (Reuters) -Activist investors have targeted major healthcare companies over the past year to push them to improve their performance, with some campaigns only coming to light after announcements of board changes. Below are some notable healthcare companies that came under activist pressure in the last 12 months. MEDTRONIC In August 2025, the medical device maker appointed two new independent directors to its board and created independent committees focused on improving its performance, after Elliott Investment Management took a large stake, making it one of the company’s biggest shareholders. AVANTOR Engine Capital targeted the life sciences firm in August 2025, urging it to bring in new board directors, cut costs and even consider a sale. CHARLES RIVER LABORATORIES The contract research firm settled with Elliott Investment Management in May 2025 by agreeing to add four new board directors and launch a strategic review of the business. NOVO NORDISK Activist hedge fund Parvus Asset Management is building a stake in the company, as investors have grown concerned that the Danish drugmaker has lost its first-mover advantage in the lucrative weight-loss drug market, the Financial Times reported in June 2025. Reuters has not independently verified the report. GERRESHEIMER London-based investment fund Asset Value Investors in June 2025 pressed the German medical packaging maker to find ways to restore its market value. AVI, with a 3.5% stake in Gerresheimer, said the company needs a new financial leadership to regain its credibility. ILLUMINA In March 2025, the gene-sequencing maker said activist investor Keith Meister would join its board. HENRY SCHEIN In January, private equity firm KKR built a large stake in the medical and dental supplies distributor and reached a deal to add members to the company’s board. Henry Schein (NASDAQ:HSIC) was also under pressure from other investors, including Ananym Capital Management. PFIZER Activist hedge fund Starboard Value in October 2024 called for management accountability for the company’s underperformance. This month, Starboard increased its holding in the drugmaker to 8.5 million shares, which represented about 0.15% of the outstanding shares as of June end. KENVUE In October 2024, Starboard Value took a significant stake in the Band-Aid maker, criticizing the weak performance of its skin health segment, which houses Neutrogena, Aveeno and other brands. After a proxy battle, the companies reached a deal in early 2025 that gave Starboard CEO Jeffrey Smith and two independent directors board seats. CVS HEALTH In November, CVS Health (NYSE:CVS) added Glenview Capital’s top boss and three others to its board as part of a deal with the hedge fund. The company had been under pressure from investors, including Glenview, to improve operations after missing financial targets several times due to rising medical costs in its health insurance business. Glenview reduced its stake in the company after CVS posted strong results in May. With HSIC making headlines, savvy investors are asking: Is it truly valued fairly? In a market full of overpriced darlings, identifying true value can be challenging. InvestingPro's advanced AI algorithms have analyzed HSIC alongside thousands of other stocks to uncover hidden gems. These undervalued stocks, potentially including HSIC, could offer substantial returns as the market corrects. In 2024 alone, our AI identified several undervalued stocks that later surged by 30 or more. Is HSIC poised for similar growth? Don't miss the opportunity to find out.

Click Subscribe #Healthcare #ActivistInvestors #StockMarket #InvestorRelations #CorporateGovernance

0 0 0 0
Preview
Activist investors slow pace of demands amid global uncertainties-data By Svea Herbst-Bayliss NEW YORK(Reuters) -Activist investors who push companies for operational changes and management shake-ups waged fewer campaigns during the first half of 2025 as tariffs, wars and U.S. President Donald Trump’s unpredictable policies made them more cautious, new data show. The pace of investor demands, aimed at pushing up a company’s share price, fell 12% to 129 campaigns launched during the first six months of 2025, compared with 147 a year ago, according to numbers compiled by investment bank Barclays. "The environment was shaped by mixed economic signals, fears about wars and geopolitical tensions and the instability created by future tariffs and trade wars," said Jim Rossman, global head of shareholder advisory at Barclays. "And taken together that is creating an environment of caution." The slowdown comes after a record number of corporate agitators made demands last year and the pace of campaigns jumped by 17% in the first three months of this year. Elliott Investment Management, among the world’s most powerful corporate activists, pressed for changes at six companies, including BP (NYSE:BP) and Hewlett Packard Enterprise (NYSE:HPE), roughly half the number of campaigns it launched a year ago. But it deployed $8.8 billion in assets, the most of any activist this year. Also so-called first-timers who were becoming more comfortable employing activist tactics last year stepped to the sidelines late in the first half. During the second quarter when stock markets gyrated as Trump threatened harsher tariffs only to reverse course before suggesting them again, campaigns launched by first-timers dropped 27% from the first quarter of this year, the data show. But the slowdown does not hint at a pause in activity or suggest activist investors are going soft, Rossman said. Corporate agitators, including Mantle Ridge, Ancora Holdings and Jana Partners have, as a group, forced bigger changes at companies in the first half of this year than a year ago, the data show. Settlements between activist investors and companies jumped 32% to 37 in the first half of 2025 and left activists with 86 board seats, marking a 16% increase. They won seats, often a measure of success for activists, at companies ranging from industrial gases maker Air Products and Chemicals (NYSE:APD) to food processing company Lamb Weston. "As a group activists are having a strong year, winning settlements and board seats and managing to engage with a number of companies privately," Rossman said. Most activists continue to focus their attention on companies in the United States with 60 campaigns launched, down from 61 a year earlier. There were 37 campaigns in Japan, down from 51 a year ago. Activity in Europe declined by 17% to 24 campaigns launched in the first half compared with a year ago.

Click Subscribe #ActivistInvestors #Investing #StockMarket #InvestmentTrends #BusinessNews

0 0 0 0
Fortrea stock rises after adopting poison pill as activists swirl Investing.com -- Fortrea (NASDAQ:FTRE) stock rose 5% in pre-open trading Thursday after the contract research organization announced it had adopted a limited-duration stockholder rights plan to protect shareholder interests. The company said its board unanimously approved the plan, which will expire on June 10, 2026, unless terminated earlier. The rights plan was implemented in response to "significant and ongoing dislocation" in the company’s stock price and recent interest from third parties looking to capitalize on the situation. While Fortrea did not specifically name any parties, activist hedge funds Starboard Value and Corvex Management have significant stakes in the company. Starboard owned 5,268,000 shares in the first quarter, while Corvex held 4,474,898 shares during the same period. Under the rights plan, Fortrea will issue one right for each share of common stock as of June 23, 2025. These rights will become exercisable if any person or group acquires 10% or more of the company’s outstanding common stock. If triggered, all rights holders except the triggering party would be entitled to acquire shares at a 50% discount, or the company may exchange each right for one share of common stock. The plan allows current shareholders who already own more than the triggering percentage to maintain their positions but prevents them from acquiring additional shares without triggering the rights plan. Barclays is serving as strategic advisor to Fortrea, with Smith Anderson acting as legal advisor. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C. Should you invest $2,000 in FTRE right now? Before you buy stock in FTRE, consider this: ProPicks AI are 6 easy-to-follow model portfolios created by Investing.com for building wealth by identifying winning stocks and letting them run. Over 150,000 paying members trust ProPicks to find new stocks to buy – driven by AI. The ProPicks AI algorithm has just identified the best stocks for investors to buy now. The stocks that made the cut could produce enormous returns in the coming years. Is FTRE one of them?

Click Subscribe #Fortrea #StockMarket #Investing #ActivistInvestors #PoisonPill

0 0 0 0
SSP shares jump 5% as activist investor pushes for profitability boost INvesting.com -- Irenic Capital Management, a New York-based activist investor, is building a stake in SSP Group (LON:SSPG) and intends to pressure the company to boost its profitability, setting the stage for a potential private equity takeover, the Financial Times reported on Friday. Shares of the food service company were up 5.7% at 05:30 ET (10:30 GMT). Irenic has acquired around a 2% stake in the FTSE 250 company, which operates food outlets in airports and railway stations, the report said, citing sources familiar with the matter. The activist investor has made it clear that it believes SSP’s share price could be worth double its current valuation, advocating for the company to improve its profit margins. The hedge fund, which plans to continue purchasing more shares, has held multiple meetings with SSP management, though no specific demands have been made as of yet, sources added. Irenic’s previous campaign included targeting The Restaurant Group (LON:RTN), owner of Wagamama, which was successfully sold to Apollo in 2023. While Irenic declined to comment on its latest move, SSP responded by stating that it is in regular dialogue with all of its investors, welcoming their feedback as part of its efforts to drive progress on its strategic priorities, the report said. The company reiterated its commitment to delivering sustainable growth and returns for its stakeholders. SSP has faced difficulties in recovering from the pandemic. The group, which also owns Ritazza and operates travel outlets for brands like Burger King and Marks & Spencer (OTC:MAKSY), has struggled with the slow recovery of rail travel, which has not yet rebounded to pre-pandemic levels.

Click Subscribe #SSP #ActivistInvestors #StockMarket #Investing #Profitability

0 0 0 0
Preview
Insider Buying 03-28-25 Stagflation is the Game. Confidence has been Shattered The market as measured by the S&P 500 shed 1.53% last month. The dollar was down, gold up. There seems […]

graphical programs, AI can only take you to 90% of the solution. The commodification of AI is well underway, and Autodesk is actively adapting.
Read the full analysis: bit.ly/4ccBV2N
#InsiderBuying #TheInsidersFund #ADSK #SaaS #ActivistInvestors #GenerativeAI #TechInvesting #FinancialAnalysis

1 0 0 0
TOMS Capital pushes for Kenvue sale, Bloomberg News reports © Reuters. (Reuters) -Investment firm TOMS Capital Investment Management has amassed a stake in the Band-Aid maker Kenvue (NYSE:KVUE) and is pushing the company to consider a full sale or separation of some assets, Bloomberg News reported on Sunday, citing people with knowledge of the matter. It was not immediately clear the extent of the hedge fund’s total stakeholding in Kenvue. Kenvue, previously a part of Johnson & Johnson (NYSE:JNJ), settled a four-month battle with activist investor Starboard Value earlier this month by appointing three new directors to its board as part of an agreement. Starboard Value built a stake in Kenvue in October, sparking criticism over the lackluster performance in the skin health and beauty segment, which houses brands such as Neutrogena and Aveeno. TOMS Capital declined to comment and Kenvue did not immediately respond to a Reuters request for comment, while a spokesperson for Kenvue told Bloomberg News, "Kenvue’s board and management team are committed to acting in the best interests of the company and all shareholders and we remain focused on accelerating sustainable, profitable growth and enhancing shareholder value." Which stock should you buy in your very next trade? AI computing powers are changing the stock market. Investing.com's ProPicks AI includes 6 winning stock portfolios chosen by our advanced AI. In 2024 alone, ProPicks AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. Which stock will be the next to soar? Unlock ProPicks AI 0 Latest comments

Click Subscribe #TOMSCapital #Kenvue #InvestmentNews #StockMarket #ActivistInvestors

0 0 0 0
Preview
a close up of a cricket crawling on a floor . Alt: a close up of a cricket crawling on a floor .

Somebody check my logic here

1) Activist investors threaten Target for DEI
2) Stock price goes down
3) Activist investors sue, Target for stock price going down

#activistinvestors #sillyhumans #iwelcomeournewaioverlords

0 0 0 0